相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure-Based Drug Design
Giuseppe Luna et al.
CHEMMEDCHEM (2019)
In silico study of febuxostat analogs as inhibitors of xanthine oxidoreductase: A combined 3D-QSAR and molecular docking study
Xiaolei Li et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Chemistry and Pharmacology of Flavonoids- A Review
Avtar Chand Rana et al.
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH (2019)
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
MaryAnn Zhang et al.
CIRCULATION (2018)
Design, synthesis and biological evaluation of 1-hydroxy-2-phenyl-4pyridyl-1H-imidazole derivatives as xanthine oxidase inhibitors
Tingjian Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
Andreas Jordan et al.
PHARMACEUTICALS (2018)
Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors
Jing Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor
Manroopraj Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity
Andrija Smelcerovic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
Rosa Maria Vitale et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors
Ting-jian Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study
T. Hosoya et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
Synthesis and bioevaluation of 2-phenyl-5-methyl-2H-1,2,3-triazole-4-carboxylic acid/carbohydrazide derivatives as potent xanthine oxidase inhibitors
Ailong Shi et al.
RSC ADVANCES (2016)
Synthesis, crystal structures, fluorescence and xanthine oxidase inhibitory activity of pyrazole-based 1,3,4-oxadiazole derivatives
De-Qiang Qi et al.
JOURNAL OF MOLECULAR STRUCTURE (2015)
Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors
Qi Guan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
New Therapies for Gout
Daria B. Crittenden et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits
Chandrika B-Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors
Kunal Nepali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors
Kunal Nepali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase
Koji Matsumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors
Shaojie Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Febuxostat: A Novel Non-Purine Selective Inhibitor of Xanthine Oxidase for the Treatment of Hyperuricemia in Gout
Kuang-Hui Yu
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2007)
Gout medication treatment patterns and adherence to standards of care from a managed care perspective
CA Sarawate et al.
MAYO CLINIC PROCEEDINGS (2006)
Y-700 [1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]:: A potent xanthine oxidoreductase inhibitor with hepatic excretion
A Fukunari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors
S Ishibuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
C Enroth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
